Caxton Associates (New York)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,341
Closed -$2.68M 587
2024
Q2
$2.68M Hold
18,341
0.09% 119
2024
Q1
$2.9M Hold
18,341
0.16% 83
2023
Q4
$2.87M Buy
18,341
+12,216
+199% +$1.87M 0.15% 83
2023
Q3
$954K Sell
6,125
-6,094
-50% -$1.01M 0.13% 156
2023
Q2
$2.02M Sell
12,219
-16,729
-58% -$2.7M 0.3% 68
2023
Q1
$4.49M Buy
28,948
+12,945
+81% +$2.09M 0.68% 22
2022
Q4
$2.83M Buy
16,003
+12,446
+350% +$2.15M 0.19% 31
2022
Q3
$581K Sell
3,557
-2,333
-40% -$395K 0.08% 211
2022
Q2
$1.05M Buy
+5,890
New +$1.05M 0.1% 117
2022
Q1
Sell
-6,805
Closed -$1.16M 604
2021
Q4
$1.16M Buy
6,805
+3,984
+141% +$652K 0.12% 88
2021
Q3
$456K Sell
2,821
-41,517
-94% -$7.08M 0.05% 221
2021
Q2
$7.3M Buy
+44,338
New +$7.34M 0.8% 19
2020
Q3
Sell
-2,115
Closed -$297K 417
2020
Q2
$297K Buy
+2,115
New +$308K 0.03% 261
2019
Q4
Sell
-6,224
Closed -$805K 472
2019
Q3
$805K Buy
+6,224
New +$820K 0.16% 64
2019
Q1
Sell
-2,319
Closed -$299K 441
2018
Q4
$299K Buy
+2,319
New +$323K 0.05% 182
2018
Q3
Sell
-10,704
Closed -$1.3M 470
2018
Q2
$1.3M Buy
10,704
+177
+2% +$22.1K 0.07% 138
2018
Q1
$1.35M Sell
10,527
-650
-6% -$87.9K 0.07% 160
2017
Q4
$1.56M Buy
11,177
+5,777
+107% +$805K 0.08% 157
2017
Q3
$702K Buy
+5,400
New +$716K 0.03% 237

Other funds holding JNJ

Caxton Associates (New York)'s JNJ Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 18,341 shares — an estimated $2.68M sold.

Caxton Associates (New York) first reported a position in JNJ in Q3 2017 and held it in 19 quarters. The position peaked at $7.3M in Q2 2021. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 18,341 Johnson & Johnson shares in Q3 2024, an estimated $2.68M.
  • Caxton Associates (New York) first reported a position in Johnson & Johnson in Q3 2017 and held it in 19 quarters.
  • Caxton Associates (New York)'s Johnson & Johnson position peaked at $7.3M in Q2 2021.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.